Genmab — December 2012
-
Der kommer ikke en emission i genmab
-
Vel som et af de eneste biotekselskaber?
-
Og ingen obligationsgæld heller
-
Ja en velo. Byt din mercedes ud med en cykel
-
Jeg glæder mig til firm guidance for jeg forstår ikke alt det nye daratumumab og duobody. Han siger jo at han har lejet alt ud nu med margin
-
Hvis de begynder at guide cashflow positiv med 1,5 mia i kassen, så rykker vi!
-
I emissionskursen
-
Jeg går på talerstolen næsten gang (igen)
-
De har rigeligt plads. Tror han fedtspiller arzerra
-
Om 5 år så
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind